BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 367159)

  • 21. Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections.
    Sweet RL; Ledger WJ
    Obstet Gynecol; 1979 Aug; 54(2):193-8. PubMed ID: 460753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the safety and efficacy of parenteral ticarcillin/clavulanate and clindamycin/gentamicin in serious intra-abdominal infections.
    Fink MP; Helsmoortel CM; Arous EJ; Doern GV; Moriarty KP; Fairchild PG; Townsend PL
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():147-56. PubMed ID: 2691476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clindamycin phosphate in severe infections mainly caused by Bacteroides fragilis: clinical and microbiological evaluation.
    Schoutens E; Van Beers D; Yourassowsky E
    Infection; 1974; 2(2):59-63. PubMed ID: 4367028
    [No Abstract]   [Full Text] [Related]  

  • 24. Carbenicillin and ticarcillin.
    Neu HC
    Med Clin North Am; 1982 Jan; 66(1):61-77. PubMed ID: 7038341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ticarcillin-clavulanate therapy for bacterial skin and soft tissue infections.
    File TM; Tan JS
    Rev Infect Dis; 1991; 13 Suppl 9():S733-6. PubMed ID: 1925317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-dependent inhibition of experimental arterial thrombosis by carbenicillin and ticarcillin.
    Lyman BT; Johnson GJ; White JG
    Am J Pathol; 1978 Aug; 92(2):473-90. PubMed ID: 677271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clindamycin in the treatment of serious anaerobic infections.
    Fass RJ; Scholand JF; Hodges GR; Saslaw S
    Ann Intern Med; 1973 Jun; 78(6):853-9. PubMed ID: 4713566
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro activity and in vivo evaluation of ticarcillin plus clavulanic acid against aerobic and anaerobic bacteria.
    Bansal MB; Chuah SK; Thadepalli H
    Am J Med; 1985 Nov; 79(5B):33-8. PubMed ID: 4073093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical evaluation of a ticarcillin-clavulanic acid combination in severe infections in adults].
    Lacut JY; Quentin C; Cardoso-Mendes I; Dupon M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):591-5. PubMed ID: 3937132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amdinocillin: use alone or in combination with cefoxitin or carbenicillin-ticarcillin.
    Lawson RD; Estey EH; Bodey GP
    Am J Med; 1983 Aug; 75(2A):113-8. PubMed ID: 6310998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ticarcillin for treatment of serious infections with gram-negative bacteria.
    Parry MG; Neu HC
    J Infect Dis; 1976 Nov; 134(5):476-85. PubMed ID: 825582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibacterial effects of ticarcillin/clavulanic acid in animal models of infection.
    Boon RJ; Beale AS; Sutherland R
    J Antimicrob Chemother; 1986 May; 17 Suppl C():41-6. PubMed ID: 3087934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of ticarcillin plus clavulanic acid in the treatment of infections of soft tissue, bone, and joint.
    Johnson CC; Reinhardt JF; Wallace SL; Terpenning MS; Helsel CL; Mulligan ME; Finegold SM; George WL
    Am J Med; 1985 Nov; 79(5B):136-40. PubMed ID: 4073081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of anaerobic pulmonary infections; carbenicillin compared to clindamycin and gentamicin.
    Thadepalli H; Niden AH; Huang JT
    Chest; 1976 Jun; 69(6):743-6. PubMed ID: 1277892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ticarcillin/clavulanic acid combination. Treatment of bacterial infections in hospitalized children.
    Kristjansson K; Cox F; Taylor L
    Clin Pediatr (Phila); 1989 Nov; 28(11):521-4. PubMed ID: 2805557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ticarcillin and clavulanic acid in serious infections.
    Kosmidis J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():169-75. PubMed ID: 3636332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical studies of BRL 28500 (clavulanic acid/ticarcillin) in the treatment of intraperitoneal infections and biliary tract infections].
    Sakai K; Ueda T; Uchino J; Hayasaka A; Shiramatsu K; Nagamachi Y; Shoda Y; Okui K; Hayata Y; Watanabe H
    Jpn J Antibiot; 1987 Apr; 40(4):759-811. PubMed ID: 3302345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical experience with Timentin in severe hospital infections.
    Meylan PR; Calandra T; Casey PA; Glauser MP
    J Antimicrob Chemother; 1986 May; 17 Suppl C():127-39. PubMed ID: 3636328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New penicillins in the treatment of urinary tract infection.
    Geedes AM; McGhie D; Hutchison JG; Mahood CB
    Kidney Int Suppl; 1975 Aug; 4():S134-7. PubMed ID: 811918
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of penetrating abdominal trauma and gynecologic infections.
    Levine DP; Wilson RF
    J Reprod Med; 1988 Jun; 33(6 Suppl):598-602. PubMed ID: 3294406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.